HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
A
Agilent Technologies Inc
Healthcare Diagnostics & Research · California, USA · Reports in usd
Market Cap: $44.93B
Market Cap
$44.93B
Enterprise Val
$46.48B
P/E Ratio
31.78
P/B Ratio
6.31
Trailing PEG (1Y)
0.53
As Of
Aug 20, 2026

Overview & Key Metrics

Reporting period: Apr 30, 2026 · Q2 2026
Book Value$7.12B
Gross Margin53.95%
Profit Margin53.95%
Return on Equity20.84%
Return on Assets11.13%
Current Ratio2.10
Debt/Equity0.47
LT Debt/Equity0.43
Revenue Per Share6.49

Income Statement

Apr 30, 2026
Revenue$1.84B
Cost of Revenue$845.0M
Gross Profit$990.0M
R&D$126.0M
SG&A$465.0M
Operating Expenses$591.0M
Operating Income$399.0M
Interest Expense$25.0M
Tax Expense$69.0M
Net Income$339.0M
EPS (Basic)$1.20
EPS (Diluted)$1.20
EBIT$433.0M
EBITDA$500.0M
Consolidated Income$339.0M
Non-Controlling Interests$0.00

Balance Sheet

Apr 30, 2026
Cash & Equivalents$1.81B
Accounts Receivable$1.50B
Inventory$1.09B
Current Assets$4.76B
LT Investments$136.0M
Property, Plant & Equipment$2.10B
Intangibles$4.89B
Non-Current Assets$8.30B
Total Assets$13.07B
Accounts Payable$615.0M
Current Debt$304.0M
Current Liabilities$2.27B
LT Debt$3.05B
Non-Current Liabilities$3.67B
Total Liabilities$5.94B
Total Debt$3.36B
Retained Earnings$1.69B
Shareholder Equity$7.12B
Shares Outstanding282,602,317

Cash Flow Statement

Apr 30, 2026
Operating Cash Flow$277.0M
Investing Cash Flow-$77.0M
Financing Cash Flow-$144.0M
CapEx-$76.0M
Free Cash Flow$201.0M
Depreciation & Amort.$67.0M
Stock-Based Comp$32.0M
Acquisitions / Disposals$0.00
Investment Activity-$1.0M
Debt Issued/Repaid-$3.0M
Equity Issued/Repaid-$64.0M
Dividends Paid-$72.0M
Net Change in Cash$49.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h